- Home
- HCM vs APGE Comparison
HCM vs APGE Comparison
Compare HCM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- APGE
- Stock Information
- Founded
- HCM 2000
- APGE 2022
- Country
- HCM Hong Kong
- APGE United States
- Employees
- HCM N/A
- APGE N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HCM Health Care
- APGE Health Care
- Exchange
- HCM Nasdaq
- APGE Nasdaq
- Market Cap
- HCM 2.6B
- APGE 2.4B
- IPO Year
- HCM N/A
- APGE 2023
- Fundamental
- Price
- HCM $15.10
- APGE $52.10
- Analyst Decision
- HCM Sell
- APGE Strong Buy
- Analyst Count
- HCM 1
- APGE 8
- Target Price
- HCM $13.75
- APGE $94.63
- AVG Volume (30 Days)
- HCM 43.6K
- APGE 883.1K
- Earning Date
- HCM 08-07-2025
- APGE 11-11-2025
- Dividend Yield
- HCM N/A
- APGE N/A
- EPS Growth
- HCM N/A
- APGE N/A
- EPS
- HCM 0.53
- APGE N/A
- Revenue
- HCM $602,197,000.00
- APGE N/A
- Revenue This Year
- HCM N/A
- APGE N/A
- Revenue Next Year
- HCM $15.49
- APGE N/A
- P/E Ratio
- HCM $5.61
- APGE N/A
- Revenue Growth
- HCM N/A
- APGE N/A
- 52 Week Low
- HCM $11.51
- APGE $26.20
- 52 Week High
- HCM $21.50
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- HCM 39.12
- APGE 64.95
- Support Level
- HCM $14.86
- APGE $39.21
- Resistance Level
- HCM $15.34
- APGE $57.63
- Average True Range (ATR)
- HCM 0.32
- APGE 3.30
- MACD
- HCM -0.06
- APGE 0.34
- Stochastic Oscillator
- HCM 7.79
- APGE 76.49
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.